This Article Full Text Full Text (PDF) All Versions of this Article: 47/6/1125    most recent 01.HYP.0000221223.23028.f1v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van der Linde, N. A.J. Articles by van den Meiracker, A. H. Search for Related Content PubMed PubMed Citation Articles by van der Linde, N. A.J. Articles by van den Meiracker, A. H. Related Collections Lipids Other Vascular biology Pathophysiology

(Hypertension. 2006;47:1125.)
© 2006 American Heart Association, Inc.

Original Articles

Effect of Low-Density Lipoprotein Cholesterol on Angiotensin II Sensitivity

A Randomized Trial With Fluvastatin

Nicole A.J. van der Linde; Eric J.G. Sijbrands; Frans Boomsma; Anton H. van den Meiracker

From the Department of Internal Medicine and Vascular Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Correspondence to Anton H. van den Meiracker, Erasmus Medical Center, Department of Internal Medicine–D432, Dr. Molewaterplein 40, PO Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail a.vandenmeiracker{at}erasmusmc.nl

Increased angiotensin II (Ang II) sensitivity predisposes to hypertension and plaque instability. Raised low-density lipoprotein cholesterol (LDL-c) may increase Ang II sensitivity, but evidence in humans for this effect of LDL-c is limited. In 28, healthy, nonsmoking subjects, aged 30±8 years, with familial hypercholesterolemia, we determined the difference in infusion rate of Ang II and norepinephrine required to increase systolic blood pressure by 20 mm Hg (Pd-20) after 4 weeks of placebo and fluvastatin 80 mg daily in a randomized, double-blind, placebo-controlled, crossover study. Before infusions were started, fasting blood samples were taken to measure lipids. After 4 weeks of placebo, the mean LDL-c concentration was 6.3±1.4 mmol/L. The average decrease of LDL-c was 1.7±0.7 mmol/L after 4 weeks of fluvastatin (P<0.001). The mean Pd-20 for Ang II increased by 1.28 ng/kg per minute (95% CI, 2.05 to 0.50; P=0.002) on fluvastatin, corresponding with a 26% decrease in Ang II sensitivity. Ang II sensitivity, however, remained increased compared with normocholesterolemic controls. The Pd-20 values for norepinephrine were unaffected by fluvastatin. The present study in healthy, young subjects with isolated hypercholesterolemia shows an increased sensitivity to Ang II that partly can be restored by LDL-c–lowering therapy. These findings indicate that LDL-c levels directly influence Ang II sensitivity.

Key Words: angiotensin • blood pressure • cholesterol • hypercholesterolemia • lipoproteins • statins

This article has been cited by other articles:

				J. Sanchez-Quinones, F. Marin, V. Roldan, and G.Y.H. Lip The impact of statin use on atrial fibrillation QJM, August 24, 2008; (2008) hcn101v1. [Abstract] [Full Text] [PDF]

				L. Paulsen, C. Holm, J. N. Bech, J. Starklint, and E. B. Pedersen Effects of statins on renal sodium and water handling: Acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1556 - 1561. [Abstract] [Full Text] [PDF]